Results 181 to 190 of about 5,747 (197)

Immunoproteasome subunit deficiency has no influence on the canonical pathway of NF-κB activation

Molecular Immunology, 2017
Daniel Krappmann, Marcus Groettrup, Michael Basler   +2 more
exaly  

Differential processing of class-I-restricted epitopes by the standard proteasome and the immunoproteasome

Current Opinion in Immunology, 2001
Benoit van den Eynde
exaly  

Oxathiazolones Selectively Inhibit the Human Immunoproteasome over the Constitutive Proteasome

ACS Medicinal Chemistry Letters, 2014
J David Warren, Carl Nathan, Gang Lin
exaly  

Selective Inhibition of the Immunoproteasome by Ligand‐Induced Crosslinking of the Active Site

Angewandte Chemie - International Edition, 2014
Christian Dubiella, Rob Liskamp, Haissi Cui   +2 more
exaly  

Nonpeptidic Selective Inhibitors of the Chymotrypsin‐Like (β5 i) Subunit of the Immunoproteasome

Angewandte Chemie - International Edition, 2016
Dusanka Janežič, Damijan Knez, Samo Lesnik   +2 more
exaly  

Immunoproteasome as a biomarker for immunotherapy

Nature Reviews Cancer
openaire   +2 more sources

A bright approach to the immunoproteasome: Development of LMP2/β1i-specific imaging probes

Bioorganic and Medicinal Chemistry, 2012
Chang-Guo Zhan, Marie Wehenkel
exaly  

Interferon-dependent immunoproteasome activity during mouse adenovirus type 1 infection

Virology, 2016
Sharlene Day, Jason Weinberg, Saul R Powell   +2 more
exaly  

COMPOUNDS FOR IMMUNOPROTEASOME INHIBITION

2011
SHENK KEVIN D, PARLATI FRANCESCO, BENNETT MARK K   +2 more
openaire   +4 more sources

IMMUNOPROTEASOME INHIBITOR ANALOGS

2017
PIRRUNG MICHAEL C, BAKAS NICOLE A, BACHMANN ANDRE   +2 more
openaire   +4 more sources